Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leigh Goedeke

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Molecular Metabolism|August 15, 2022
Insulin increases placental triglyceride as a potential mechanism for fetal adiposity in maternal obesityAnika K Anam, Katherine M Cooke, Milana Bochkur Dratver, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2022
Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesisTraci E LaMoia, Gina M Butrico, Hasini A Kalpage, et al.
Iscience|November 11, 2024
High-fat-diet-induced hepatic insulin resistance <i>per se</i> attenuates murine <i>de novo</i> lipogenesisLeigh Goedeke, Jordan W Strober, Rebecca Suh, et al.
Science Translational Medicine|July 15, 2026
A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in miceBernardo Gindri Dos Santos, Niki F Brisnovali, Connor Haney, et al.
Circulation Research|March 23, 2013
Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144Cristina M Ramírez, Noemi Rotllan, Alexander V Vlassov, et al.
Cell Reports|February 22, 2018
Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin ResistanceNathan L Price, Abhishek K Singh, Noemi Rotllan, et al.
Science Advances|December 4, 2024
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney diseaseSwayam Prakash Srivastava, Han Zhou, Rachel Shenoi, et al.
Nature Medicine|October 6, 2015
MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levelsLeigh Goedeke, Noemi Rotllan, Alberto Canfrán-Duque, et al.
Diabetes|December 1, 2016
Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 DiabetesPeter Willeit, Philipp Skroblin, Alexander R Moschen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2011
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signalingAlberto Dávalos, Leigh Goedeke, Peter Smibert, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Molecular Metabolism|August 15, 2022
Insulin increases placental triglyceride as a potential mechanism for fetal adiposity in maternal obesityAnika K Anam, Katherine M Cooke, Milana Bochkur Dratver, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2022
Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesisTraci E LaMoia, Gina M Butrico, Hasini A Kalpage, et al.
Iscience|November 11, 2024
High-fat-diet-induced hepatic insulin resistance <i>per se</i> attenuates murine <i>de novo</i> lipogenesisLeigh Goedeke, Jordan W Strober, Rebecca Suh, et al.
Science Translational Medicine|July 15, 2026
A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in miceBernardo Gindri Dos Santos, Niki F Brisnovali, Connor Haney, et al.
Circulation Research|March 23, 2013
Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144Cristina M Ramírez, Noemi Rotllan, Alexander V Vlassov, et al.
Cell Reports|February 22, 2018
Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin ResistanceNathan L Price, Abhishek K Singh, Noemi Rotllan, et al.
Science Advances|December 4, 2024
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney diseaseSwayam Prakash Srivastava, Han Zhou, Rachel Shenoi, et al.
Nature Medicine|October 6, 2015
MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levelsLeigh Goedeke, Noemi Rotllan, Alberto Canfrán-Duque, et al.
Diabetes|December 1, 2016
Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 DiabetesPeter Willeit, Philipp Skroblin, Alexander R Moschen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2011
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signalingAlberto Dávalos, Leigh Goedeke, Peter Smibert, et al.
Pageof 6